Olink Holding AB (OLK)
22.96
+0.29
(+1.28%)
USD |
NASDAQ |
May 02, 13:40
Olink 1 Year Total Returns (Daily): 7.03% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 01, 2024 | 7.03% |
| April 30, 2024 | 6.77% |
| April 29, 2024 | 8.25% |
| April 26, 2024 | 8.50% |
| April 25, 2024 | 10.12% |
| April 24, 2024 | 3.65% |
| April 23, 2024 | 1.32% |
| April 22, 2024 | 0.55% |
| April 19, 2024 | -1.35% |
| April 18, 2024 | 1.92% |
| April 17, 2024 | -2.19% |
| April 16, 2024 | 0.40% |
| April 15, 2024 | 0.75% |
| April 12, 2024 | 9.45% |
| April 11, 2024 | 6.28% |
| April 10, 2024 | 3.99% |
| April 09, 2024 | 6.63% |
| April 08, 2024 | 7.05% |
| April 05, 2024 | 3.79% |
| April 04, 2024 | 3.40% |
| April 03, 2024 | -0.59% |
| April 02, 2024 | 4.26% |
| April 01, 2024 | 4.31% |
| March 28, 2024 | 18.44% |
| March 27, 2024 | 9.31% |
| Date | Value |
|---|---|
| March 26, 2024 | 5.53% |
| March 25, 2024 | 7.15% |
| March 22, 2024 | 7.38% |
| March 21, 2024 | 4.52% |
| March 20, 2024 | 10.96% |
| March 19, 2024 | 7.67% |
| March 18, 2024 | 7.49% |
| March 15, 2024 | 8.48% |
| March 14, 2024 | 8.67% |
| March 13, 2024 | 8.27% |
| March 12, 2024 | 9.17% |
| March 11, 2024 | 9.04% |
| March 08, 2024 | 1.28% |
| March 07, 2024 | 1.08% |
| March 06, 2024 | -3.40% |
| March 05, 2024 | -4.60% |
| March 04, 2024 | -4.65% |
| March 01, 2024 | 1.10% |
| February 29, 2024 | -4.56% |
| February 28, 2024 | -3.80% |
| February 27, 2024 | 2.74% |
| February 26, 2024 | -1.04% |
| February 23, 2024 | -7.11% |
| February 22, 2024 | -0.45% |
| February 21, 2024 | -2.22% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-74.80%
Minimum
Jun 13 2022
141.1%
Maximum
Jun 13 2023
1.12%
Average
7.93%
Median
1 Year Total Returns (Daily) Benchmarks
| Thermo Fisher Scientific Inc | 5.11% |
| Abliva AB | -- |
| Karolinska Development AB | 0.00% |
| Calliditas Therapeutics AB | -17.43% |
| Oncopeptides AB | -53.66% |